RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro

INTRODUCTION: Bisphosphonates are the most widely used class of drug for inhibiting osteoclast-mediated bone loss, but their effectiveness at preventing joint destruction in rheumatoid arthritis has generally been disappointing. We examined whether the ability of bisphosphonates to induce osteoclast...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutherland, Karen A, Rogers, Helena L, Tosh, Denise, Rogers, Michael J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688211/
https://www.ncbi.nlm.nih.gov/pubmed/19405951
http://dx.doi.org/10.1186/ar2681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688211/
https://www.ncbi.nlm.nih.gov/pubmed/19405951
http://dx.doi.org/10.1186/ar2681

Ejemplares similares